In
Interline Ther
S San Francisco CAFounded 201940 employees
Private CapbiotechPrivateOncology
Platform: Multispec Ab
Market Cap
N/A
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| INT-5527 | INT-5527 | Phase 2 | 2 | PD-L1 | Ewing SarcomaHS | ||
| INT-430 | INT-430 | Phase 2/3 | 1 | CD19 | RACholangiocarcinoma |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (1)